On November 28th, Xie Jun, Director of Quality Metrology Supervision and Testing Institute of Zhongshan City, Guangdong Province; Dong Lianhua, Researcher of Chinese Academy of Metrology; Sun Jing, Deputy Director of the Achievement Transformation Department of Shanghai Institute of Materia Materia, Chinese Academy of Sciences; Gu Yinming, Commercial Director of the Achievement Transformation Department of Zhongshan Pharmaceutical Innovation Research Institute; Peng Yonglin, Deputy General manager of Zhongshan Bioengineering Co., LTD.; Liu Jingde, Director of Quality Assurance Department of Zhongshan Bioengineering Co., LTD. Guo Jingmei, Quality director of Zhongshan Weiming Haiji Biomedicine Co., LTD., and Fan Qinghua, metrology director of Zhongshan Kangfang Biomedicine Co., LTD., visited Guangdong Junhou Biomedicine Co., LTD. (hereinafter referred to as "Junhou Biology"), a wholly-owned subsidiary of Shenzhen Cell Valley. Dr. Feng Yaru, Executive President and production director of Junhou Biology, and Zhang Xuefeng, quality director, warmly received and exchanged views.


First of all, under the leadership of Dr. Feng Yaru and Director Zhang Xuefeng, the visiting leaders and enterprise representatives visited the smart exhibition hall and production and testing laboratory of Junhou Biology, and had a preliminary understanding of the company's development history, core team, core technology platform and production pipeline.

At the symposium, Dr. Feng Yaru expressed his sincere thanks to the leaders, experts and enterprise representatives for their visit and concern, and introduced the development history of Junhou Biology, the industrial production advantages of the core technology - retroviral vector, the company's development strategy and the recent process development achievements. Dr. Feng stressed that Junhou Biology, as the only enterprise that can carry out GMP grade retrovirus vector CDMO outsourcing production, has always believed that "product quality is the life of the enterprise and is the cornerstone of long-term development of the enterprise" from the beginning to the present. This concept was highly recognized by the leaders, experts and business representatives at the meeting. The two sides had a heated discussion on how to give full play to Junhou's technical advantages in the field of innovative cell drug production and assist in the formulation of national biometric special testing standards, and defined the basic cooperation framework.

This exchange visit promoted the benign communication between the company and the national authoritative metrology institutions and colleagues in the biological industry, and jointly helped the cutting-edge scientific research in the medical industry.